首页 | 本学科首页   官方微博 | 高级检索  
     


A first-in-man phase I trial of a new monoclonal antibody labelled with yttrium 90 for radioimmunotherapy of relapsed or refractory non resectable synovial-sarcomas
Authors:J. Badel  C. Desuzinges  S. Rey  S. Baconnier  D. Perol  G. Garin  P. Cassier  J. Blay  Y. Nakamura  C. Fukukawa  T. Mognetti
Affiliation:Centre Léon Bérard, Lyon, France;Laboratoires OncoTherapy Science, France, Lyon, France;Institute of Medical Science, University of Tokyo, Tokyo, Japan;4OncoTherapy Science, Kanagawa, Japan
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号